GlassScriptPhysician profile
John Thomas Peters
NPI 1376531103
$71,085.66
in general payments reported to CMS, 2019-2025
47 companies · $10K in 2025
The $10K reported for 2025 was more than what 93% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,420 · 2020: $6,967 · 2021: $22K · 2022: $6,866 · 2023: $13K · 2024: $5,410 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Education: $9,107 · Food and Beverage: $8,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,600.00 |
| Education | $9,107.37 |
| Food and Beverage | $8,063.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $42,712.85 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Intuitive Surgical, INC. | $9,694.07 | 2023-2025 | Ion, Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,167.86 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $2,374.93 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Actelion Pharmaceuticals US, INC. | $2,159.01 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Olympus Corporation of The Americas | $931.40 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $894.39 | 2019-2025 | Dupixent |
| Insmed, INC. | $700.36 | 2020-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $468.44 | 2020-2025 | Glassia, Cuvitru |
| Genzyme Corporation | $436.09 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $433.17 | 2019-2025 | |
| United Therapeutics Corporation | $428.49 | 2021-2025 | Tyvaso, Remodulin, Orenitram |
| Merck Sharp & Dohme LLC | $344.66 | 2021-2025 | Winrevair, Zerbaxa, Recarbrio |
| Amgen INC. | $272.29 | 2022-2025 | Tezspire, Tavneos |
| Paratek Pharmaceuticals, INC. | $243.91 | 2020-2024 | Nuzyra |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $213.79 | 2019-2023 | Yupelri |
| Sunovion Pharmaceuticals INC. | $182.05 | 2019-2020 | |
| Electromed, INC. | $177.13 | 2021-2024 | Smartvest |
| Gilead Sciences, INC. | $154.29 | 2019-2025 | Veklury |
| Verona Pharma, INC. | $96.86 | 2025 | Ohtuvayre |
| Ethicon INC. | $91.56 | 2019-2022 | |
| Grifols USA, LLC | $71.50 | 2020-2023 | Prolastin-C Liquid |
| Boston Scientific Corporation | $71.20 | 2022-2024 | Embold Fibered |
| Baxter Healthcare | $55.63 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Vapotherm INC | $54.58 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $53.26 | 2020-2021 | |
| Pfizer INC. | $48.90 | 2019-2020 | |
| Genentech USA, INC. | $46.83 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $46.78 | 2022 | |
| Inogen, INC. | $44.17 | 2025 | |
| Portola Pharmaceuticals, LLC | $39.61 | 2019-2020 | |
| Fisher & Paykel Healthcare INC | $39.00 | 2022 | |
| Abbvie INC. | $37.01 | 2024 | |
| Circassia INC. | $32.94 | 2019 | |
| Livanova USA, INC. | $29.25 | 2021 | |
| Masimo Corporation | $26.23 | 2021 | |
| Alexion Pharmaceuticals, INC. | $23.09 | 2022 | |
| Pulmonx Corporation | $22.39 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Celgene Corporation | $22.27 | 2023 | Reblozyl |
| Ambu INC. | $22.02 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.09 | 2019 | |
| Medtronic, INC. | $18.94 | 2021 | |
| Viatris Specialty LLC | $18.19 | 2025 | Yupelri |
| Resmed Corp | $18.03 | 2022 | |
| Csl Behring | $16.69 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.30 | 2021 | |
| Veran Medical Technologies, INC. | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.